CreatorsPublishersAdvertisers
View more in
Public Health

People with MS Not at Greater Risk for Guillain Barré Syndrome from J&J COVID-19 Vaccine

nationalmssociety.org
 2021-07-13

The benefits of vaccination against COVID-19 continue to outweigh the risks even with a new warning from the Food and Drug Administration (FDA). On July 12, the FDA requested that Janssen: Pharmaceutical Companies of Johnson & Johnson (J & J) add a warning to its COVID-19 vaccine Emergency Use Authorization Fact Sheet for Healthcare Providers regarding the risk of a potential side effect known as Guillain Barré Syndrome:

www.nationalmssociety.org

Comments / 0

Comments / 0